GB0208331D0 - Proteins - Google Patents

Proteins

Info

Publication number
GB0208331D0
GB0208331D0 GB0208331A GB0208331A GB0208331D0 GB 0208331 D0 GB0208331 D0 GB 0208331D0 GB 0208331 A GB0208331 A GB 0208331A GB 0208331 A GB0208331 A GB 0208331A GB 0208331 D0 GB0208331 D0 GB 0208331D0
Authority
GB
United Kingdom
Prior art keywords
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0208331A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Glycosciences UK Ltd
Original Assignee
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Glycosciences UK Ltd filed Critical Oxford Glycosciences UK Ltd
Priority to GB0208331A priority Critical patent/GB0208331D0/en
Publication of GB0208331D0 publication Critical patent/GB0208331D0/en
Priority to PCT/GB2003/001587 priority patent/WO2003087832A2/en
Priority to PCT/GB2003/001559 priority patent/WO2003087831A2/en
Priority to AT03717443T priority patent/ATE347106T1/en
Priority to ES03717443T priority patent/ES2274220T3/en
Priority to JP2003584724A priority patent/JP2005522226A/en
Priority to DE60310059T priority patent/DE60310059T2/en
Priority to AU2003222606A priority patent/AU2003222606A1/en
Priority to EP03717443A priority patent/EP1497656B1/en
Priority to AU2003222604A priority patent/AU2003222604A1/en
Priority to US10/510,507 priority patent/US20050282165A1/en
Priority to US11/986,786 priority patent/US20090258019A1/en
Priority to JP2009284846A priority patent/JP2010117358A/en
Ceased legal-status Critical Current

Links

GB0208331A 2002-04-11 2002-04-11 Proteins Ceased GB0208331D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GB0208331A GB0208331D0 (en) 2002-04-11 2002-04-11 Proteins
US10/510,507 US20050282165A1 (en) 2002-04-11 2003-04-10 Diagnosis of Carcinoma Using RAIG1 Polypeptides
DE60310059T DE60310059T2 (en) 2002-04-11 2003-04-10 DIAGNOSIS OF CARCINOMA WITH THE HELP OF RAIG1 POLYPEPTIDE
PCT/GB2003/001559 WO2003087831A2 (en) 2002-04-11 2003-04-10 Proteins involved in breast cancer
AT03717443T ATE347106T1 (en) 2002-04-11 2003-04-10 DIAGNOSIS OF CARCINOMA USING THE RAIG1 POLYPEPTIDE
ES03717443T ES2274220T3 (en) 2002-04-11 2003-04-10 CARCINOMA DIAGNOSIS USING RAIG1 POLYPEPTIDES.
JP2003584724A JP2005522226A (en) 2002-04-11 2003-04-10 Proteins involved in cancer
PCT/GB2003/001587 WO2003087832A2 (en) 2002-04-11 2003-04-10 Diagnosis of carcinoma using raigi polypeptides
AU2003222606A AU2003222606A1 (en) 2002-04-11 2003-04-10 Diagnosis of carcinoma using raigi polypeptides
EP03717443A EP1497656B1 (en) 2002-04-11 2003-04-10 Diagnosis of carcinoma using raig1 polypeptides
AU2003222604A AU2003222604A1 (en) 2002-04-11 2003-04-10 Proteins involved in breast cancer
US11/986,786 US20090258019A1 (en) 2002-04-11 2007-11-26 Diagnosis of carcinoma using RAIG1 polypeptides
JP2009284846A JP2010117358A (en) 2002-04-11 2009-12-16 Protein involved in cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0208331A GB0208331D0 (en) 2002-04-11 2002-04-11 Proteins

Publications (1)

Publication Number Publication Date
GB0208331D0 true GB0208331D0 (en) 2002-05-22

Family

ID=9934645

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0208331A Ceased GB0208331D0 (en) 2002-04-11 2002-04-11 Proteins

Country Status (3)

Country Link
AU (1) AU2003222604A1 (en)
GB (1) GB0208331D0 (en)
WO (1) WO2003087831A2 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005124357A1 (en) * 2004-06-18 2005-12-29 Roche Diagnostics Gmbh Use of protein elongation factor-1-alpha-1 as a marker for breast cancer
US7807789B2 (en) * 2004-12-21 2010-10-05 Cell Signaling Technology, Inc. Reagents for the detection of protein phosphorylation in EGFR-signaling pathways
WO2006116541A2 (en) * 2005-04-27 2006-11-02 Caprion Pharmaceuticals, Inc. Tat-002 and methods of assessing and treating cancer
GB0520067D0 (en) * 2005-10-01 2005-11-09 Cancer Rec Tech Ltd Treatment of cancer
GB0611116D0 (en) * 2006-06-06 2006-07-19 Oxford Genome Sciences Uk Ltd Proteins
WO2008005556A2 (en) * 2006-07-07 2008-01-10 9183-4663 Quebec Incorporated Tat-048 and methods of assessing and treating cancer
GB0621279D0 (en) * 2006-10-26 2006-12-06 Nat Blood Service Binding site
FR2919064B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD OF ASSAYING APOLIPOPROTEIN ALL FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
FR2919061B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD OF DOSING PLASTINE-I FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER.
FR2919060B1 (en) * 2007-07-19 2012-11-30 Biomerieux Sa METHOD OF DETERMINING EZRINE FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
EP2171467B1 (en) 2007-07-19 2016-01-13 bioMérieux Method for the assay of liver fatty acid-binding protein, ace and ca19-9 for the in vitro diagnosis of colorectal cancer
FR2919065B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD FOR DETERMINING APOLIPOPROTEIN AI FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
FR2919062B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD OF DETERMINING AMINOACYLASE 1 FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER.
FR2919063B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD OF DETERMINING LEUCOCYTE ELASTASE INHIBITOR FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER.
AU2008329529B2 (en) * 2007-11-27 2015-02-19 The University Of British Columbia 14-3-3 eta antibodies and uses thereof for the diagnosis and treatment of arthritis
FR2933773B1 (en) 2008-07-10 2013-02-15 Biomerieux Sa METHOD FOR DETERMINING THE ISOMERASE DISULFIDE PROTEIN FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
FR2940125B1 (en) 2008-12-23 2013-03-22 Isp Investments Inc COSMETIC OR PHARMACEUTICAL SOOTHING COMPOSITION COMPRISING AN ACTIVATOR PEPTIDE OF HMG-COA REDUCTASE
FR2940291B1 (en) * 2008-12-23 2012-12-21 Isp Investments Inc PEPTIDE DERIVED FROM HMG-COA REDUCTASE AND COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
ES2714216T3 (en) 2009-03-11 2019-05-27 Augurex Life Sciences Corp Compositions and methods to characterize arthritic conditions
US8933036B2 (en) 2009-04-15 2015-01-13 Isp Investments Inc. Cosmetic and/or pharmaceutical composition comprising a yeast peptide hydrolysate and use of the yeast peptide hydrolysate as an active agent for strengthening hair
FR2944526B1 (en) 2009-04-15 2013-05-10 Isp Investments Inc COSMETIC AND / OR PHARMACEUTICAL COMPOSITION COMPRISING A PEPTIDE HYDROLYZATE CAPABLE OF STRENGTHENING BARRIER FUNCTION
FR2944445B1 (en) 2009-04-15 2013-08-16 Isp Investments Inc COSMETIC AND / OR PHARMACEUTICAL COMPOSITION COMPRISING A SOOTHING PEPTIDE HYDROLYZATE
DK3144394T3 (en) * 2010-12-08 2019-05-13 Expression Pathology Inc SRM / MRM test for the truncated HER2
EP2768851B1 (en) 2011-10-21 2017-05-31 Augurex Life Sciences Corporation Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
ES2526468B2 (en) * 2013-06-07 2015-08-07 Universidad Complutense De Madrid Method of selection of specific antibodies of European hake (Merluccius merluccius) to assign individuals to their populations according to whether they are of Atlantic origin or of Mediterranean origin.
GB201520546D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
WO2017100663A1 (en) 2015-12-09 2017-06-15 Expression Pathology, Inc. Improved methods for treating her2-positive breast cancer
IT202000016807A1 (en) * 2020-07-10 2022-01-10 Humanitas Mirasole Spa PEPTIDES ASSOCIATED WITH CANCER AND THEIR USE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS626169A (en) * 1985-07-03 1987-01-13 Mochida Pharmaceut Co Ltd Reagent for diagnosing cancer
GB0004576D0 (en) * 2000-02-25 2000-04-19 Oxford Glycosciences Uk Ltd Proteins
DE60126248T2 (en) * 2000-02-25 2007-07-05 Ucb S.A. USE OF BREAST CANCER MEMBRANE PROTEINS FOR TREATMENT, PROPHYLAXIS AND DIAGNOSIS OF BREAST CANCER

Also Published As

Publication number Publication date
AU2003222604A1 (en) 2003-10-27
WO2003087831A3 (en) 2004-07-29
AU2003222604A8 (en) 2003-10-27
WO2003087831A2 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
GB0208331D0 (en) Proteins
GB0209884D0 (en) Proteins
GB0220770D0 (en) Proteins
EP1487874A4 (en) Falp proteins
GB0212067D0 (en) Proteins
IL169260A0 (en) Il-8 -like proteins
GB0201808D0 (en) Protein
AU2003270055A8 (en) Neurotransmission-associated proteins
AU2003278718A8 (en) Stars-a muscle-specification-binding protein
AU2003300785A8 (en) Carbohydrate-associated proteins
AU2003295760A8 (en) Organelle-associated proteins
GB0214543D0 (en) Proteins
GB0216757D0 (en) Proteins
GB0202748D0 (en) Protein
GB0221564D0 (en) Proteins
GB0204500D0 (en) Proteins
GB0211903D0 (en) Proteins
GB0217631D0 (en) Proteins
GB0218039D0 (en) Proteins
GB0219053D0 (en) Proteins
GB0220768D0 (en) Proteins
GB0211525D0 (en) Proteins
GB0210440D0 (en) Proteins
GB0221567D0 (en) Proteins
GB0222512D0 (en) Proteins

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)